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Abstract
Background: The decline in malaria coinciding with the introduction of newer, costly anti-malarials has prompted 
studies into the overtreatment for malaria mostly in East Africa. The study presented here describes prescribing 
practices for malaria at health facilities in a West African country.
Methods: Cross-sectional surveys were carried out in two urban Gambian primary health facilities (PHFs) during and 
outside the malaria transmission season. Facilities were comparable in terms of the staffing compliment and capability 
to perform slide microscopy. Patients treated for malaria were enrolled after consultations and blood smears collected 
and read at a reference laboratory. Slide reading results from the PHFs were compared to the reference readings and 
the proportion of cases treated but with a negative test result at the reference laboratory was determined.
Results: Slide requests were made for 33.2% (173) of those enrolled, being more frequent in children (0-15 yrs) than 
adults during the wet season (p = 0.003). In the same period, requests were commoner in under-fives compared to 
older children (p = 0.022); however, a positive test result was 4.4 times more likely in the latter group (p = 0.010). 
Parasitaemia was confirmed for only 4.7% (10/215) and 12.5% (37/297) of patients in the dry and wet seasons, 
respectively. The negative predictive value of a PHF slide remained above 97% in both seasons.
Conclusions: The study provides evidence for considerable overtreatment for malaria in a West African setting 
comparable to reports from areas with similar low malaria transmission in East Africa. The data suggest that laboratory 
facilities may be under-used, and that adherence to negative PHF slide results could significantly reduce the degree of 
overtreatment. The "peak prevalence" in 5-15 year olds may reflect successful implementation of malaria control 
interventions in under-fives, but point out the need to extend such interventions to older children.
Background
In malaria endemic areas, the lack of specific features and
adequate laboratory diagnostic facilities often limits the
capacity of health workers to establish a definitive diag-
nosis of malaria. Given the potentially lethal conse-
quences of a missed diagnosis of malaria, case
management guidelines had adopted a presumptive
approach to treatment for the febrile child in areas con-
sidered endemic for disease [1]. Given the high disease
burden, and the availability of cheap and effective anti-
malarials, this was considered a cost-effective approach
to care [2] and is acknowledged to have contributed to
the reduction in morbidity and mortality in preschool
children [3,4].
With reports of declining incidence of malaria [5-10]
and now almost universal introduction of artemisinin-
based combination therapy (ACT), there have been
increasing calls for improving the way diagnosis and case
management for malaria is conducted, with a flurry of
diagnostic options [11-14]. This follows because it has
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been well documented that presumptive anti-malarial
treatment of febrile cases results in considerable over-
diagnosis and treatment across varying transmission set-
tings [15-21]. For instance, a large scale study in north-
east Tanzania revealed that 54% of hospital admitted
patients treated for malaria had no evidence of Plasmo-
dium  infection as assessed by expert slide microscopy
[19]. Since these patients were usually not investigated or
treated for other potentially life-threatening diagnoses,
the case fatality rate in the malaria parasite negative
group presumptively diagnosed was 1.75-fold higher than
in the parasite positive group.
With declining incidence of malaria, adherence to the
reflex to treat any febrile case for malaria is likely to put
proportionately more patients at risk of not receiving
appropriate treatment. Also, the indiscriminate use of
ACT has major cost implications and potentially
increases the risk of an emergence of resistance [22,23].
To address these issues, accurate data are needed on the
degree of overtreatment from presumptive diagnosis in
different populations [24,25].
The bulk of the literature on the subject reports from
studies in East Africa in areas with different degrees of
malaria transmission. The aim of this study is to provide
comparative evidence from a West African country with
a distinctly seasonal malaria transmission pattern. The
study, therefore, investigated prescription practices
immediately following artemether-lumefantrine (AL)
introduction as first-line treatment in the Gambia, during
and outside of the annual malaria transmission season.
The implications of these findings on case management
and diagnostic options are discussed.
Methods
Health facility survey
Two cross-sectional surveys were carried out at two pri-
mary health facilities (PHFs) serving predominantly
urban populations within the Western Division of The
Gambia, to coincide with the periods of low transmission
(May to July) and peak malaria transmission (August -
October) respectively. The study was carried out in 2008
shortly after the introduction of AL into the health sys-
tem as the first-line treatment for uncomplicated malaria.
Both PHFs have laboratory facilities for blood slide
microscopy and the outpatient clinics are run by state
enrolled nurses trained in the use of the national malaria
treatment guideline. The guideline reflects the WHO
guideline in identifying symptoms which could indicate
malaria and encourages the use of microscopy for diagno-
sis where available but permits presumptive treatment on
the basis of clinical suspicion without a confirmatory test
since not all health facilities in the country have support-
ing laboratories [26]. Eligibility for this study was based
on a patient seen and treated for malaria by the attending
health worker; no attempt was made to interfere with the
consultation process. Patients were sequentially enrolled
however; those already on anti-malarials prior to presen-
tation and those, requiring in-patient care were excluded.
Written informed consent was obtained after consulta-
tion, and information on presenting complaints, duration
of illness, diagnosis made and treatment given were col-
lected onto case report forms. In addition, a finger prick
blood sample was collected from each participant for a
blood slide and this was read at the Medical Research
Council's haematology (reference) laboratory at Fajara. A
film was declared negative if no asexual form of P. falci-
parum was seen on examining 100 high-power fields.
The outpatient register used to record attendance and
treatments was reviewed to document the total number
of people seen and treated for malaria at the PHFs
throughout the study period since study recruitment was
restricted to working hours on week days only.
Sample size determination
Studies elsewhere evaluating the proportion of slide neg-
ative cases who received anti-malarial treatment have
reported values between 62% [15] in areas of perennial
transmission and 86% [27] for areas with unstable low
transmission. The study hypothesized that prescription
patterns would differ during outside the transmission
season and aimed to detect at least a 15% difference
between seasons. For a 5% significance level with 80%
power, and taking into account incomplete data entry, a
minimum estimate of 207 patients were enrolled at each
time point; 414 in all. This sample size took into account
possible differences in the age distribution of patients
between seasons and balanced selection of patients into
predefined age strata at the point of recruitment, based
on the age distribution of malaria cases documented in
the outpatient registers for the previous year.
Data processing and analysis
Microsoft Access 2003 (Microsoft Inc, Redmond, WA,
USA) was used for double entry, validation and verifica-
tion of the data. The analysis was carried out using
STATA, version 10 (Stata Corp, College Station, Tx,
USA). The outcome for the study was the proportion of
cases that received anti-malarial treatment, but had a
negative blood slide result from the reference laboratory
reading. Logistic regression models including age groups
(<5, 5-15, >15 years), season and interaction terms for age
groups and season were performed. Subgroup analysis
was carried out for children (<5 and 5-15 years). Sensitiv-
ity and specificity of the health centre slide readings com-
pared to the MRC readings was evaluated in the
subgroup of patients who had a request for microscopy
made at the health facility.Okebe et al. Malaria Journal 2010, 9:180
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Ethical approval
The study was approved by the Gambian Government/
MRC Joint Ethics Committee.
Results
Description of sample population
About 8,410 patients were recorded as being treated for
malaria at both facilities during the study period; 1,502 in
the dry and 6,908 in the wet seasons respectively. A total
of 521 patients treated for malaria were enrolled, but
analysis was carried out using data for 513 patients; 215
and 298 during the dry and wet seasons respectively
(eight entries were excluded due to incomplete data)(Fig-
ure 1). The distribution of patients by age category and
sex in both survey periods is shown in Table 1. All but five
patients reported a history of fever with a median dura-
tion of three days (range 1 - 60 days) before presentation,
although temperatures were not measured routinely at
the PHFs.
Health facility performance: slide requests and results
A request for microscopy was made in 33.2% (173) of
those enrolled (Table 2). Slide requests were significantly
more common for children (0-15 yrs) than adults (>15
years) in the wet season (p = 0.003), but not during the
dry season (p = 0.64). Among the adults, a higher propor-
tion received slide requests during the dry season com-
pared to the wet season (p = 0.018). While the proportion
of slide requests was similar for children below and above
five years of age in the dry season (p = 0.205), a signifi-
cantly higher proportion of those under five years
received a request compared to those above five years in
the wet season (p = 0.022).
Overall, a blood slide was scored positive in 52.4% of
the children and 48.9% of adults tested in both seasons
(Table 3). Considering that all those enrolled received
anti-malarials despite their test result, this would infer an
overtreatment rate of 48.6% based on the PHF laboratory
result. Ninety-five percent of those treated received the
recommended AL. There was no significant association
between test result and anti-malarial prescribed (p =
0.060).
Notable differences were observed in the proportion of
confirmed cases in the different age categories, and in
both seasons. During the dry season the proportion of
positive cases declined with age, while in the wet (trans-
mission) season, the highest proportion of positive cases
were reported in the age group 5-15 years, with children
in that age category being 4.4 times more likely to have a
positive result compared to those <5 years old. Also, chil-
dren within the 5-15 years age group had significantly
more positive cases in the wet season compared to the
dry season (p = 0.03).
Evaluating malaria treatment based on reference 
microscopy results
The reference slide readings suggest considerably lower
parasite prevalence amongst those treated for malaria.
Only 9.2% of the 512 patients enrolled and treated for
malaria had parasitaemia at the time of diagnosis; 4.7%
(10/215) in the dry season and 12.5% (37/297) in the wet
season (p = 0.003, Table 4). Conversely, this infers that
95.3% (95% CI: 92.5% - 98.2%) and 87.5% (95% CI: 83.8% -
91.3%) of those who received anti-malarials in the dry
and wet seasons respectively may have been treated
wrongly as judged by the reference slide reading. This
averages to an overtreatment rate of 90.8% (95% CI: 90.2%
- 91.4%) for both seasons. The reference slide reading
confirms that the odds of a positive slide result are high-
est in the 5-15 years age category across both seasons.
Figure 2 compares the slide reading results from both lab-
oratories stratified according to age groups according to
season.
The proportion of patients overtreated according to age
is shown in Table 5 and indicate that children <5 years are
most significantly misdiagnosed and treated for malaria
compared to other age groups for both seasons. Extrapo-
lation of the numbers of cases unnecessarily treated for
malaria based on the number of malaria diagnoses docu-
mented at the recruitment site over the study period
would suggest that 7,636 (95% CI: 7,586 - 7,686) of the
8,410 may have received anti-malarials for illnesses other
than malaria.
Accuracy of health facility slide reporting
To determine the accuracy of the PHF slide results, they
were compared to those obtained at the reference labora-
tory used as the standard.
During the wet season, the sensitivity of slide reporting
was quite high at 93.8% but the ability to identify true
non-malaria cases was low with a specificity of 45.7%.
Though sensitivities did not differ significantly between
seasons (p = 0.37), specificity was significantly higher
Table 1: Age and sex distribution of patients by season
Season N (%)
Age category 
(years)
Dry Wet
<5 89 (41.4) 124 (41.6)
5-15 54 (25.1) 78 (26.2)
>15 72 (33.5) 96 (32.2)
Sex
Male 103 (47.9) 136 (45.6)
Female 112 (52.1) 162 (54.4)Okebe et al. Malaria Journal 2010, 9:180
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Figure 1 Distribution of patients between seasons showing numbers (%) in the different comparison groups studied.
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during the dry season (p = 0.037, Table 6). While the pos-
itive predictive value of a PHF slide was low, being 10%
during the dry season and 25.4% in the wet season, the
negative predictive value (NPV) remained high being
97.8% and 97.3% in both the dry and wet season, respec-
tively.
Discussion
Presumptive diagnosis of malaria previously advocated
for malaria endemic areas may have always resulted in
some degree of overtreatment. With the decline in
malaria prevalence reported from several parts of sub-
Saharan Africa [9,10,28,29], adherence to this approach is
likely to increase the degree of overtreatment and inevita-
bly a failure to treat alternative causes of fever. Indeed,
studies in critically ill patients treated for "malaria"
showed significantly higher mortality in those with a neg-
ative slide compared to those with a positive slide [19,30].
An economic layer is added to this problem with an
increasing number of countries now using relatively
costly ACT currently as the first line of defence against
malaria. These are important reasons to develop treat-
ment strategies targeting those who actually have malaria
and requires a better understanding of the phenomenon
of malaria overdiagnosis.
Overtreatment has been reported from many parts of
East Africa, mainly from areas with low to moderate or
high perennial transmission [15,16,19,21]. The pattern is
Table 2: Health centre slide requests
Age category Dry season [n/N (%)] † Wet season [n/N (%)] † OR (95% CI) p-value
<5 years
(213)
27/89 (30.3) 55/124 (44.4) 1.83 (1.03-3.25) 0.039
5 - 15 years
(132)
22/54 (40.7) 22/78 (28.2) 0.57 (0.27-1.19) 0.135
>15 years
(168)
27/72 (37.5) 20/96 (20.8) 0.44 (0.22-0.87) 0.018
†N-total number per age category/season
* Requests in the wet season compared to the dry seasonOkebe et al. Malaria Journal 2010, 9:180
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likely to vary across different epidemiologic settings, but
little has been known from areas where malaria incidence
has dropped to very low levels [31], and data are lacking
from West Africa. Here, data on prescription practices in
the Gambia, where malaria is highly seasonal [32] and
where incidence has declined to unprecedentedly low lev-
els [9] are presented.
The observations indicate that PHF workers under-uti-
lize the available laboratory facility in making decisions
on diagnosis. Despite the availability of slide reading at
the health centres, a slide was only requested in about 1/3
of the cases diagnosed with malaria. Interestingly, this
proportion remained stable throughout the year despite
the fact that substantially more patients are seen during
the wet than in the dry season and suggests that the
capacity to perform slide reading is unlikely to be the lim-
iting factor.
The low use of the laboratory facilities supports other
reports [24,33], and may in part be explained by the mis-
trust in the quality of the slide reading [34], which may be
justified. While the sensitivity of the microscopic diagno-
sis performed at the PHF was acceptable compared to the
reference slide, the specificity was unacceptably poor,
resulting in a high number of "false positives". Thus, simi-
lar to reports from East Africa [35], slide reading at the
PHF has an extremely poor positive predictive value,
which argues in favour of presumptive treatment.
However, as has been shown previously [19,31], a nega-
tive slide did not necessarily exclude a patient from
receiving malaria treatment. The negative predictive
value was high in both the dry season (97.8%) and the wet
season (97.3%), which would have allowed exclusion of
slide negative cases from anti-malarial treatment with
high confidence. Adherence to the policy to withhold
malaria treatment from patients with a negative slide
result could, therefore, save a significant amount of over-
treatment without significantly increasing the risk of
missing true malaria cases but achieving compliance with
this policy is obviously challenging.
The data presented here indicate that the health work-
ers tend to target children less than five years of age for
slide requests, particularly during the transmission sea-
son. While the focus on this age group probably reflects
the impact of programmes such as the Integrated Man-
agement of Childhood Illnesses (IMCI), the increased use
of parasitological diagnostics in this age group (for which
the IMCI guideline advocated presumptive treatment),
may be influenced by more recent local guidelines that
promote the use of diagnostics where available. It is con-
ceivable that the recommendation to perform parasito-
Table 3: Proportions and odds of slide positive results at the PHF laboratories
Season Age category Sample Slide positive (%) OR (95% CI) p-value
Dry <5 years 27 15 (55.6) 1
5 - 15 years 22 10 (45.5) 0.67 (0.22 - 2.07) 0.483
>15 years 27 5 (18.5) 0.18 (0.05 - 0.62) 0.007
Wet <5 years 55 24 (43.6) 1
5 - 15 years 22 17 (77.3) 4.39 (1.42 - 13.60) 0.010
>15 years 20 18 (90) 11.63 (2.46 - 55.05) 0.002
Table 4: Reference laboratory results for malaria parasitaemia in both seasons
MRC slide results N = 512 (%)* ORs 95% CI p-value
DRY 10/215 (4.65)
<5 1/89 (1.1) 1
5-15 7/54 (13.0) 13.11 1.565 - 109.73 0.018
>15 2/72 (2.8) 2.51 0.223 - 28.30 0.455
WET 37/297 (12.46)
<5 9/123 (7.32) 1
5-15 17/78 (21.8) 3.53 1.485 - 8.390 0.004
>15 11/96 (11.5) 1.64 0.650 - 4.132 0.295
Total 47/512 (9.2)
* One slide washed off during preparationOkebe et al. Malaria Journal 2010, 9:180
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logical diagnostics is perceived primarily as an additional
layer of measures aimed to improve care in those already
identified as risk groups.
However, microscopic diagnosis of blood slides from all
participants at the reference laboratory show that, among
those for whom a slide reading was requested, the highest
prevalence of malaria parasites was in 5-15 year old chil-
dren; these being 3.5 and 13.1 fold more likely to have
parasitaemia in the wet and dry seasons respectively than
children under the age of five years. To some extent this
may be confounded by the fact that care-givers are more
likely to bring younger children to the PHF when they are
febrile, and that febrile disease due to a variety of causes
other than malaria may simply be more prevalent in
younger compared to older children. However, a cross
sectional survey carried out recently in healthy Gambians
similarly identified the peak parasite prevalence occur-
ring in 10-15 year olds [9]. It would be tempting to specu-
late that this may be the result of consequent
implementation of malaria control strategies in under
fiver year olds, but up to date information on bed net cov-
erage in the study area is lacking. Taken together, this
suggests that in areas of low malaria transmission the tar-
get group for malaria control measures should be
enlarged to include children up to the age of 15 years.
The most remarkable observation, however, is that in
the wet season, 87.5% had no detectable parasitaemia on
the reference slide. During the dry season 4.6 times less
patients received malaria treatment, but among those, the
proportion of unnecessarily administered anti-malarials
was even higher, being 95.3%. Several reports from East
Africa have recently documented malaria overdiagnosis,
and - although only few studies simultaneously measured
transmission by means of entomological inoculation rates
(EIR) - it appears that overdiagnosis seems to increase as
transmission declines. In areas of perennial [15] and
moderate [19] transmission in Tanzania, 62% and 54% of
malaria treatments were found to be unnecessary, respec-
tively, whereas overtreatment rates of 86% [27] and 75%
[16] were reported from areas in East Africa where trans-
mission was classified as low and unstable. One recent
study in Tanzania measured both transmission and the
degree of overtreatment at the same time and determined
that where the EIR was 0.69 by mosquito sampling, 99.6%
of patients receiving anti-malarials had no slide-detect-
able parasitaemia [31]. Comparable data here for the
Gambia [9,36] for the year preceding this survey, sup-
ports the notion that over-prescription may relate
inversely with a decline in the level of malaria transmis-
sion.
In order to treat patients appropriately and to ensure
the sustainability of ACT and to protect the "useful
lifespan" of such drug combinations, the new guidelines
from WHO recommend that a laboratory test should be
performed before treating [37]. Therefore, efforts are
being made to improve access to parasitological diagnos-
tics. Presently, the options available are to increase capac-
ity to carry out microscopy or the widespread use of rapid
malaria diagnostic test kits (RDTs).
Attempts to step up the capacity of slide reading are
likely to be of limited success, as microscopy depends on
reliable electricity supply and requires considerable skill
and expertise. RDTs in a dipstick format appear to be an
attractive alternative for parasitological diagnosis. RDTs
do not require particular skills or electricity and can be
performed at the point of care by the PHF worker. How-
ever, procurement of RDTs is probably only a modest
proportion of the cost of integrating RDTs into a health
Figure 2 Comparison of slide reading results between laborato-
ries for both seasons, stratified by age category.
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Table 5: Overtreatment estimates in both seasons across age groups in the sample
Age category % overtreatment (95% CI)
Dry season <5 98.9% (96.6 - 101.1)
5-15 87.0% (77.8 - 96.4)
>15 97.2% (93.3 - 101.1)
Wet season <5 92.7% (82.1 - 97.4)
5-15 78.2% (68.8 - 87.6)
>15 88.5% (82.1 - 90.3)Okebe et al. Malaria Journal 2010, 9:180
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system. The challenges of forecasting RDT needs, manag-
ing procurement and distribution through the supply-
chain should not be underestimated.
Discussions about the best way forward have stimu-
lated a vibrant debate with strong advocacy in favour [38]
and against [39] the rapid implementation of RDT. While
RDTs perform at least as well as microscopy in diagnos-
ing malaria, it appears clinicians are reluctant to refrain
from treating for malaria even after a negative test [40].
Surprisingly, the fact that RDTs can be performed by the
PHF worker did not enhance adherence to the test result,
and in particular children under five years with a negative
RDT were more likely to be prescribed an anti-malarial
than those with a negative slide [40,41]. Mathematical
modelling using data across a broad range of malaria
transmission intensities concludes that RDTs can be cost-
effective compared to presumptive treatment, but these
calculations assume that prescribers treat according to
test results [42], and there are conflicting data as to what
extent this could be the case in real life. In Burkina Faso, a
similar amount of overtreatment was found in patients
m a n a g e d  c l i n i c a l l y  o r  w i t h  R D T ,  i n d i c a t i n g  t h a t  t e s t
results were simply ignored [43]. In a Kenyan trial, pre-
scribing of ACT largely followed the results however
despite a negative test, 75% of children under five years
and 61% of those over five years still received an anti-
malarial [44]. In an area of Zanzibar with parasite preva-
lence ranging from 10% to 50%, the use of RDTs
improved treatment and health outcomes, without
increasing the costs for patient management [45].
It is important to note that revised WHO guidelines are
not explicit whether or not to withhold anti-malarials
from patients where there is a clinical suspicion of
malaria but a negative test result. Here, the health care
worker's decision depends on his/her trust into the qual-
ity of the test and his/her fear of the implications of a
missed diagnosis. These situations often result in the
half-hearted prescription of an anti-malarial other than
the first-line drug [44].
Thus, whether RDTs have the potential to become a
cost-effective means to improve the management of
febrile cases will depend on successful strategies to pro-
mote adherence to the result, and has to overcome the
labelling and treatment of all febrile illnesses as "malaria".
PHF workers need to be toned to make efforts to consider
other, often more difficult to establish, diagnoses and to
convince caregivers where a fever has no serious cause.
Conclusions
Despite their availability, a consistent pattern of underuse
of diagnostic facilities was seen. The proportion of
patients likely to receive an anti-malarial for a slide nega-
tive result was very high in both seasons. In the context of
other published reports this suggests the tendency to
overprescribe has increased with recent declines in trans-
mission. While RDT based diagnostic approaches have
the potential to be cost-effective, adherence to test results
remains its major determinant. Behaviour-change com-
munication campaigns will be needed to encourage with-
holding of malaria treatment from patients with a
negative diagnostic test, thus saving costs without
increasing the risk of missing out on the true malaria
cases.
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Table 6: Sensitivity and specificity of health facility results by season
Sensitivity (95% CI) Specificity (95% CI)
Dry season 0.750 (0.326- 1.00) 0.625 (0.513 - 0.737)
Wet season 0.937 (0.819- 1.00) 0.457 (0.348 - 0.565)
Comparison between seasons p = 0.37 p = 0.037Okebe et al. Malaria Journal 2010, 9:180
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